ABIOMED Inc. (ABMD) Nasdaq Global Select
CloseMay 21, 2019

News: updated – 22-May 03:53

Abiomed up 3% on FDA confirmation of safety of Impella heart pump21-May 01:55(SeekingAlpha)

In a letter to healthcare providers, the FDA states that Abiomed’s ( ABMD +2.6% ) Impella RP heart pump is safe and effective for the treatment of right heart failure. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more …

FDA Confirms Impella RP is Safe and Effective; Only Right-Sided Device with FDA Approval21-May 12:42(Business Wire)

Use of early identification protocol leads to higher survival and native heart recovery, as demonstrated in FDA studies In a letter sent to healthcare providers today, the U.S. FDA validates that Abiomeds (NASDAQ: ABMD) Impella RP heart pump is safe and effective for …

National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery21-May 12:15(Business Wire)

Improves upon AMI cardiogenic shock historical survival of 50% Abiomed(NASDAQ:ABMD) announces that new data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients from 35 sites demonstrates 72% survival with 98% na…